Dr. Al Harthy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Drive
Bethesda, MD 20814
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Rochester General HospitalResidency, Internal Medicine, 2013 - 2016
Weill Cornell Medical College in QatarClass of 2013
Certifications & Licensure
MD State Medical License 2016 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Fellow National Institutes of Health, 2017-2019
Publications & Presentations
PubMed
- 5 citationsThe changing landscape of systemic therapy in metastatic renal cell carcinoma: an update.Sandeep Gurram, Munjid Al Harthy, Mark W. Ball
Discovery Medicine. 2020-05-01 - 11 citationsClinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer.Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Munjid Al-Harthy, Marijo Bilusic
Journal for Immunotherapy of Cancer. 2021-03-01 - 8 citationsNovel immunotherapy combinations for genitourinary cancers.Munjid Al Harthy, Jason M. Redman, Ravi A. Madan
Expert Opinion on Biological Therapy. 2020-01-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
